Madrigal Pharmaceuticals shares fall 3.94% intraday after insider sold shares.

Madrigal Pharmaceuticals, Inc. declined 3.94% in intraday trading, with the company's stock price dropping following the news that an insider sold shares worth a significant amount. This event is likely perceived as bearish by investors, as it may indicate a lack of confidence in the company's future prospects.